Access cutting-edge atrial fibrillation treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access atrial fibrillation specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atrial fibrillation treatment provided free
"Afib" is a common irregular heartbeat. Afib can cause stroke, blood clots, dementia and death. Medicines used to treat Afib often do not work well and can cause serious side effects. Clinicians need medicines that work better for Afib. Medicines for Afib work by blocking a current in the heart called a potassium current. There is a newer potassium current called IKas that can contribute to Afib. A medicine called ondansetron is used to keep people with cancer from getting sick to their stomach
Sponsor: Indiana University
Check if you qualify for this atrial fibrillation clinical trial in Indianapolis, IN
If you're searching for atrial fibrillation treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.